Surging Earnings Estimates Signal Upside for Equinox Gold (EQX) Stock — Positive

EQX   Zacks Investment Research — November 25, 2025

Equinox Gold (EQX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

image for news Surging Earnings Estimates Signal Upside for Equinox Gold (EQX) Stock

Earnings Estimates Rising for Orion Marine (ORN): Will It Gain? — Positive

ORN   Zacks Investment Research — November 25, 2025

Orion Marine Group (ORN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

image for news Earnings Estimates Rising for Orion Marine (ORN): Will It Gain?

Earnings Estimates Rising for Centerra Gold (CGAU): Will It Gain? — Positive

CGAU   Zacks Investment Research — November 25, 2025

Centerra Gold Inc. (CGAU) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

image for news Earnings Estimates Rising for Centerra Gold (CGAU): Will It Gain?

Upbeat Symbotic Results Boost 2 Robotics Peers — Positive

SYM   Schaeffers Research — November 25, 2025

Symbotic Inc (NASDAQ:SYM) stock is up 36.1% to trade at $75.47 at last glance, after the robotics company reported fiscal fourth-quarter revenue of $618.5 million that surpassed analysts' estimates of $604 million.

image for news Upbeat Symbotic Results Boost 2 Robotics Peers

Nvidia fell on reports Meta may tap Google for AI chips - here's why Jim Cramer thinks investors may be overreacting. Subscribe | http://t.st/TheStreetTV Earn.

image for news Nvidia fell on reports Meta may tap Google for AI chips - why investors may be overreacting.

Novo Nordisk: Forget About Alzheimer's, The Real Catalyst Is The Wegovy Pill — Positive

NVO   Seeking Alpha — November 25, 2025

Novo Nordisk A/S remains the market leader in obesity and diabetes treatments, despite a recent sharp stock drop and failed Alzheimer's trial. The real growth catalyst for NVO is the upcoming oral semaglutide, which addresses major barriers like affordability and injection aversion. NVO is ahead of Eli Lilly in bringing an oral GLP-1 drug to market, with superior efficacy and a likely 2026 US launch.

image for news Novo Nordisk: Forget About Alzheimer's, The Real Catalyst Is The Wegovy Pill

5 Soft Drink Stocks to Hold Their Ground As Cost Pressures Mount — Negative

COCO  KDP  KO  MNST  PEP   Zacks Investment Research — November 25, 2025

About the Industry

image for news 5 Soft Drink Stocks to Hold Their Ground As Cost Pressures Mount

Alibaba Is Building Momentum — Positive

BABA   Seeking Alpha — November 25, 2025

Alibaba Group Holding Limited delivered strong Q2 FY2026 revenue growth, driven by its core e-commerce and cloud businesses, but faced significant operating margin pressures. Now, despite burning a considerable amount of cash in H1 FY2026, BABA's aggressive investments in quick commerce and AI + Cloud are fueling user growth and market leadership. With a robust net cash position and long-term growth pillars in consumption and AI + Cloud, BABA remains fundamentally strong.

image for news Alibaba Is Building Momentum

California's largest carrier1 debuts all-time high departures in San Diego New service between Hawaii and the mainland set to launch from LA-area airports DALLAS , Nov. 25, 2025 /PRNewswire/ -- Southwest Airlines Co. (NYSE: LUV) today extended its schedule for booking through September 2026 – giving Customers more options in San Diego than ever before and new offerings at three airports in Greater Los Angeles. Customers can book today at Southwest.com®.

image for news THE GOLDEN STATE GROWTH GOES ON: BOOK ON SOUTHWEST TODAY FOR LATE SUMMER 2026

Missed the AI Boom? These 2 Crushed Stocks Could Be Your Second Chance — Negative

ORCL  SMCI   MarketBeat — November 25, 2025

Last month, when concerns about an AI bubble spilled over and sparked a sell-off, stocks spent several weeks in a pullback. However, the fallout adversely affected some equities more than others—even those that have no direct ties to the AI industry.

image for news Missed the AI Boom? These 2 Crushed Stocks Could Be Your Second Chance

Analog Devices tops fiscal Q4 estimates, shares rise — Positive

ADI   Proactive Investors — November 25, 2025

Analog Devices Inc (NASDAQ:ADI) reported better-than-expected revenue and profits for the fiscal fourth quarter, sending its shares more than 4% higher on Tuesday. For the quarter ending November 1, the semiconductor company posted revenue of $3.08 billion, surpassing Wall Street estimates of $3.02 billion.

image for news Analog Devices tops fiscal Q4 estimates, shares rise

The Investment Committee discusses some of their stocks on the move and debates the latest Calls of the Day.

image for news Stocks on the move and Calls of the Day: Zoom, Applied Materials, Snowflake, Live Nation and more

J. M. Smucker: Coffee Relief Is Coming (Rating Upgrade) — Positive

SJM   Seeking Alpha — November 25, 2025

The J. M. Smucker Company is upgraded to 'hold' as coffee tariff relief should drive margin recovery in the coming quarters. SJM's Q2 showed persistent margin pressure despite 3% revenue growth, with coffee price hikes unable to fully offset tariff costs. Pet food and frozen handheld segments remain weak, while deleveraging remains a priority due to elevated debt from past M&A.

image for news J. M. Smucker: Coffee Relief Is Coming (Rating Upgrade)

How Subscribers Quintupled Their Money on Alphabet Stock — Positive

GOOG  GOOGL   Schaeffers Research — November 25, 2025

Subscribers to The Contrarian Edge received this commentary on Saturday, November 22.

image for news How Subscribers Quintupled Their Money on Alphabet Stock

New York, NY, Nov. 25, 2025 (GLOBE NEWSWIRE) -- GraniteShares, a one of the leading issuers of exchange-traded funds (ETFs), today announced the launch of two new additions to its growing YieldBOOST ™ family offering investors new ways to access income opportunities from the fast-evolving quantum computing space.

image for news UPDATED: GraniteShares Expands YieldBOOST™ Lineup with Two New ETFs on Quantum Computing Leaders RGYY and QBY

3 High-Quality Stocks Getting Stomped by the Market. Time to Buy? — Positive

AXON  BKNG  V   24/7 Wall Street — November 25, 2025

The broader market has surged to record highs in 2025, with the S&P 500 up about 14% year-to-date.

image for news 3 High-Quality Stocks Getting Stomped by the Market. Time to Buy?

Can SE's E-commerce Growth Survive Logistics & Subsidy Pressure? — Positive

SE   Zacks Investment Research — November 25, 2025

Shopee's soaring GMV and stronger monetization drive Sea Limited's e-commerce momentum, even as logistics costs and subsidy pressures tighten.

image for news Can SE's E-commerce Growth Survive Logistics & Subsidy Pressure?

CoreWeave: Your Bubble Fears Are My Value Feast — Negative

CRWV   Seeking Alpha — November 25, 2025

CoreWeave's 40% selloff from a third-party build delay and bubble chatter is timing noise in a supply-constrained AI infrastructure cycle, with demand, backlog, and build-out still ramping. With RSI deeply oversold and scenario analysis implying roughly 15%–155% 12-month upside from $72/share, CRWV offers contrarian, asymmetric returns if investors tolerate volatility and size positions near 2%. Key risks include hyperscaler concentration, leverage, and execution on ~$56 billion of backlog amid infrastructure bottlenecks, plus reliance on Nvidia's roadmap and hyperscalers' in-house silicon.

image for news CoreWeave: Your Bubble Fears Are My Value Feast

MINNEAPOLIS--(BUSINESS WIRE)--Financial advisory practice, Harpland Financial Management, recently joined the branch channel of Ameriprise Financial, Inc. (NYSE: AMP) from Wells Fargo Clearing Services, Inc. with more than $160 million in client assets. The practice, located in Houston, Texas, includes financial advisors Peter Horton, CFP®, CEPA® and Serena Sneeringer, and client service associate Micah Horton, AIF®. The team joined Ameriprise to benefit from the firm's advanced technology, int.

image for news Advisor Team With Over $160 Million in Assets Joins Ameriprise Financial for Integrated Planning Capabilities and Service Support

DuPont Can Become a ‘Compounder.' Why the Stock Could Gain 20%. — Positive

DD   Barrons — November 25, 2025

Deutsche Bank analyst David Begleiter reiterated his Buy rating on the shares. His price target is $46

image for news DuPont Can Become a ‘Compounder.' Why the Stock Could Gain 20%.